Aspira Pathlab & Diagnostics Ltd Quarterly Results
Q1 FY25-26 Results Summary
Revenue
The revenue stands at ₹5.25 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 9.17 per cent from ₹5.78 crore. This corresponds to a year-on-year *(YoY) growth of 13.15 per cent.
Operating Profit
Operating Profit stands at ₹0.68 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 26.09 per cent from ₹0.92 crore. This corresponds to a year-on-year *(YoY) growth of 151.85 per cent.
PBDT
PBDT stands at ₹0.79 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 24.76 per cent from ₹1.05 crore. This corresponds to a year-on-year *(YoY) growth of 83.72 per cent.
Profit Before Tax
Profit Before Tax stands at ₹0.42 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 38.24 per cent from ₹0.68 crore. This corresponds to a year-on-year *(YoY) growth of 740.00 per cent.
Net Profit
Net Profit stands at ₹0.42 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 38.24 per cent from ₹0.68 crore. This represents a 740.00 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Aspira Pathlab & Diagnostics Ltd Earnings
- YOY
- QOQ
Aspira Pathlab & Diagnostics Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Aspira Pathlab & Diagnostics Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Aspira Pathlab & Diagnostics Ltd Financial Reports
Aspira Pathlab & Diagnostics Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Aspira Pathlab | -1.00% | 4.31% | 9.91% | -7.25% | -8.90% | -12.69% |
| M E T S | 0.88% | -3.66% | 4.74% | 18.96% | 5.02% | -16.26% |
| Choksi Laborator | -0.34% | 6.30% | -5.50% | -3.60% | -34.62% | -13.74% |
| Sunil Healthcare | 0.00% | 0.02% | 3.31% | -10.86% | -11.61% | -8.84% |
| Shree Pacetronix | 7.70% | 12.85% | 35.27% | -3.07% | -34.13% | 106.90% |
| Amkay Products | 9.97% | 0.00% | 10.35% | -17.51% | 44.93% | 35.27% |
| Bandaram Pharma | -3.45% | 0.00% | 1.82% | -1.51% | 1.89% | -31.32% |
Company Info
Company Information
Chairman & Independent Directo : Haseeb A Drabu
Managing Director & CEO : Pankaj Jashwant Shah
Executive Director : Nikunj Mange
Independent Non Exe. Director : Manas Mengar
Company Sec. & Compli. Officer : Krupali Shah
Addtnl Independent Director : Kiran Raghavendra Awasthi